Journal of Clinical Pharmacology

SJR Rank #7,251H-index: 137SJR: 0.773Best quartile: Q2APC: US$4,150
Journal website: aims, scope and author guidelines
Publisher

Wiley-Blackwell

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • PharmacologyQ2
  • Pharmacology (medical)Q2

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmaceutical studies and practicesPharmacogenetics and Drug MetabolismAntibiotics Pharmacokinetics and EfficacyPharmacological Effects and Toxicity StudiesDrug Transport and Resistance MechanismsPharmacology and Obesity TreatmentAnalytical Methods in PharmaceuticalsCardiac electrophysiology and arrhythmiasEpilepsy research and treatmentBlood Pressure and Hypertension Studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025050100150200

Detailed Information

ISSN

1552-4604, 0091-2700

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

2.27

References per Document

36.61

Coverage

1973-2026

Scope

The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology. This includes original research in pharmacokinetics, pharmacogenetics/pharmacogenomics, pharmacometrics, physiologic based pharmacokinetic modeling, drug interactions, therapeutic drug monitoring, regulatory sciences (including unique methods of data analysis), special population studies, drug development, pharmacovigilance, womens’ health, pediatric pharmacology, and pharmacodynamics. Additionally, JCP publishes review articles, commentaries and educational manuscripts. The Journal also serves as an instrument to disseminate Public Policy statements from the American College of Clinical Pharmacology.

Metrics from SCImago Journal Rank 2025. View on SCImago